← All organizations

Spyre Therapeutics, Inc.

For profit

Also known as: Spyre Therapeutics | Spyre Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 21, 2025

Timeline

2010s

Jan 1, 2013
Spyre Therapeutics, Inc.— Founded

Drugs by trial phase (3 distinct, 6 trials)

Phase 2 (3 own, 0 via acquisition)

Recent trials (12)

NCT07148414OfficialPhase 2Aug 21, 2025
NCT07148414Lead sponsorPhase 2Aug 21, 2025
NCT07012395Lead sponsorPhase 2May 27, 2025
NCT07012395OfficialPhase 2May 27, 2025
NCT06873724Lead sponsorPhase 1Mar 10, 2025
NCT06873724OfficialPhase 1Mar 10, 2025
NCT06672718OfficialPhase 1Nov 5, 2024
NCT06672718Lead sponsorPhase 1Nov 5, 2024
NCT06622070Lead sponsorPhase 1Oct 17, 2024
NCT06622070OfficialPhase 1Oct 17, 2024
NCT06448247OfficialPhase 1Jun 6, 2024
NCT06448247Lead sponsorPhase 1Jun 6, 2024

Details

Founded: Waltham, MA, US Jan 1, 2013
Last known activity: Aug 21, 2025